Extrapolating local lymph node assay EC3 values to estimate relative sensitizing potency

被引:33
作者
Ryan, Cindy A.
Chaney, Joel G.
Gerberick, G. Frank
Kern, Petra S.
Dearman, Rebecca J.
Kimber, Ian
Basketter, David A.
机构
[1] Procter & Gamble Co, Cincinnati, OH 45202 USA
[2] Ptocter & Gamble Eurovor, Strombeek Bever, Bevr, Belgium
[3] Syngenta Cent Toxicol Lab, Macclesfield, Cheshire, England
[4] Unilever SEAC, Sharnbrook, Beds, England
关键词
EC3; value; local lymphnode assay; potency; skin sensitization;
D O I
10.1080/15569520701212258
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
The assessment of the potency of a skin sensitizing chemical is a key starting point for its subsequent risk assessmentimanagement. The Local Lymph Node Assay can provide information on the relative skin sensitizing potency of contact allergens by interpolation from the dose response curve the concentration of a chemical required to elicit a threshold positive response (EC3 value). However, interpolation requires that the dose response curve have at least one stimulation index (SI) value above and one Sl value below the threshold value of 3. For instances where all test concentrations result in Sl values above 3, there was a need to develop a method that would permit estimation of EC3 values. This has been achieved by log-linear extrapolation using the two lowest test concentrations from the dose response curve. Before applying this approach, it is important that data quality is assessed The dose response must include concentrations on the linear portion of the curve and, ideally, the SI induced by the lowest dose should approach 3. Judicious use of this approach for extrapolating EC3 values can provide information on a likely potency classification for use in risk assessment and may avoid the need for repeat animal testing.
引用
收藏
页码:135 / 145
页数:11
相关论文
共 21 条
[1]   Intravenous equipment: the beginning of things ... [J].
Ball, C ;
Westhorpe, R .
ANAESTHESIA AND INTENSIVE CARE, 2000, 28 (01) :3-3
[2]   Use of the local lymph node assay for the estimation of relative contact allergenic potency [J].
Basketter, DA ;
Blaikie, L ;
Dearman, RJ ;
Kimber, I ;
Ryan, CA ;
Gerberick, GF ;
Harvey, P ;
Evans, P ;
White, IR ;
Rycroft, RJG .
CONTACT DERMATITIS, 2000, 42 (06) :344-348
[3]   Reproducible prediction of contact allergenic potency using the local lymph node assay [J].
Basketter, DA ;
Cadby, P .
CONTACT DERMATITIS, 2004, 50 (01) :15-17
[4]  
Basketter DA, 1999, J APPL TOXICOL, V19, P261, DOI 10.1002/(SICI)1099-1263(199907/08)19:4<261::AID-JAT572>3.3.CO
[5]  
2-X
[6]   ICCVAM evaluation of the murine local lymph node assay - II. Conclusions and recommendations of an independent scientific peer review panel [J].
Dean, JH ;
Twerdok, LE ;
Tice, RR ;
Sailstad, DM ;
Hattan, DG ;
Stokes, WS .
REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2001, 34 (03) :258-273
[7]   The suitability of hexyl cinnamic aldehyde as a calibrant for the murine local lymph node assay [J].
Dearman, RJ ;
Wright, ZM ;
Basketter, DA ;
Ryan, CA ;
Gerberick, GF ;
Kimber, I .
CONTACT DERMATITIS, 2001, 44 (06) :357-361
[8]  
European Centre for Ecotoxicology and Toxicology of Chemicals (ECETOC), 2003, Technical Report No. 87: Contact sensitisation: Classification according to potency
[9]  
Gerberick G F, 2001, Am J Contact Dermat, V12, P156, DOI 10.1053/ajcd.2001.23926
[10]   Compilation of historical local lymph node data for evaluation of skin sensitization alternative methods [J].
Gerberick, GF ;
Ryan, CA ;
Kern, PS ;
Schlatter, H ;
Dearman, RJ ;
Kimber, I ;
Patlewicz, GY ;
Basketter, DA .
DERMATITIS, 2005, 16 (04) :157-202